Temporal changes in cardiac function and cerebral blood flow during sequential postmenopausal hormone replacement

Objective: The purpose was to assess the temporal changes in cardiac function and cerebral blood flow during postmenopausal administration of estrogen with and without progestogen. Study Design: Sixteen postmenopausal volunteers were assessed during estradiol plus sequential norethindrone acetate an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of obstetrics and gynecology 2001-01, Vol.184 (2), p.41-47
Hauptverfasser: Sørensen, Morten B., Fritz-Hansen, Thomas, Jensen, Henrik H., Pedersen, Anette T., Højgaard, Liselotte, Ottesen, Bent
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 47
container_issue 2
container_start_page 41
container_title American journal of obstetrics and gynecology
container_volume 184
creator Sørensen, Morten B.
Fritz-Hansen, Thomas
Jensen, Henrik H.
Pedersen, Anette T.
Højgaard, Liselotte
Ottesen, Bent
description Objective: The purpose was to assess the temporal changes in cardiac function and cerebral blood flow during postmenopausal administration of estrogen with and without progestogen. Study Design: Sixteen postmenopausal volunteers were assessed during estradiol plus sequential norethindrone acetate and placebo in two 12-week periods. Temporal changes were measured by magnetic resonance flow mapping 8 times. Results: Systemic vascular resistance was reduced during estradiol (–6.9%; P
doi_str_mv 10.1067/mob.2001.108333
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70591102</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002937801891717</els_id><sourcerecordid>70591102</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-ca1c10c811316b9d37b4932a23668dd617bc57f14cf34b61fc7da65acc79ab0c3</originalsourceid><addsrcrecordid>eNp1kE1r3DAQhkVpaLZJz70VQaE3JxrJK9nHEtIPCPSSnIU8GicqtuRIdkv_fbTs0p56Gl7mmZfhYew9iCsQ2lzPabiSQkBNnVLqFduB6E2jO929ZjshhGx6Zbpz9raUn4coe_mGnQOAaVtjduz5nuYlZTdxfHLxkQoPkaPLPjjk4xZxDSlyFz1HyjQcwGFKyfNxSr-533KIj7zQ80ZxDXW5pLLOFNPitlLjU8pzisQzLZNDqpv1kp2Nbir07jQv2MOX2_ubb83dj6_fbz7fNdhquTboAEFgB6BAD71XZmh7JZ1UWnfeazAD7s0ILY6qHTSMaLzTe4doejcIVBfs07F3yam-V1Y7h4I0TS5S2oo1Yt8DCFnB6yOIOZWSabRLDrPLfywIe7Bsq2V7sGyPluvFh1P1Nszk__EnrRX4eAJcQTeN2UUM5S_XaZByX6n-SFHV8CtQtgUDRSQfMuFqfQr_feEFhx6agQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70591102</pqid></control><display><type>article</type><title>Temporal changes in cardiac function and cerebral blood flow during sequential postmenopausal hormone replacement</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Sørensen, Morten B. ; Fritz-Hansen, Thomas ; Jensen, Henrik H. ; Pedersen, Anette T. ; Højgaard, Liselotte ; Ottesen, Bent</creator><creatorcontrib>Sørensen, Morten B. ; Fritz-Hansen, Thomas ; Jensen, Henrik H. ; Pedersen, Anette T. ; Højgaard, Liselotte ; Ottesen, Bent</creatorcontrib><description>Objective: The purpose was to assess the temporal changes in cardiac function and cerebral blood flow during postmenopausal administration of estrogen with and without progestogen. Study Design: Sixteen postmenopausal volunteers were assessed during estradiol plus sequential norethindrone acetate and placebo in two 12-week periods. Temporal changes were measured by magnetic resonance flow mapping 8 times. Results: Systemic vascular resistance was reduced during estradiol (–6.9%; P &lt;.05), declined further during the addition of norethindrone acetate, and was accompanied by an increase in stroke volume (maximum increase, 5.2%; P &lt;.05) without fluid retention. Both systolic (–5 mm Hg; P =.03) and diastolic (–3 mm Hg; P =.03) blood pressure were reduced during estradiol. Cerebral blood flow was reduced after 9 weeks of hormone replacement therapy (–37 mL/min; P =.01) but increased to baseline after the addition of norethindrone acetate. Conclusions: Sequential hormone replacement therapy is associated with changes in cardiac function, which are of therapeutic potential in cardiovascular disorders. Sequential hormone replacement therapy exhibits an overall neutral effect on cerebral blood flow. (Am J Obstet Gynecol 2001;184:41-7.)</description><identifier>ISSN: 0002-9378</identifier><identifier>EISSN: 1097-6868</identifier><identifier>DOI: 10.1067/mob.2001.108333</identifier><identifier>PMID: 11174477</identifier><identifier>CODEN: AJOGAH</identifier><language>eng</language><publisher>Philadelphia, PA: Elsevier Inc</publisher><subject>Biological and medical sciences ; Blood Pressure - drug effects ; cardiac function ; Cardiovascular Diseases - prevention &amp; control ; cerebral blood flow ; Cerebrovascular Circulation ; Cross-Over Studies ; Double-Blind Method ; Estradiol - administration &amp; dosage ; Estradiol - blood ; Estrogen Replacement Therapy ; Estrogens ; Female ; Genital system. Reproduction ; Heart - physiology ; Humans ; Magnetic Resonance Angiography ; Medical sciences ; menopause ; Middle Aged ; norethindrone ; Norethindrone - administration &amp; dosage ; Norethindrone - analogs &amp; derivatives ; Pharmacology. Drug treatments ; Placebos ; Postmenopause ; Stroke Volume - drug effects ; Vascular Resistance - drug effects</subject><ispartof>American journal of obstetrics and gynecology, 2001-01, Vol.184 (2), p.41-47</ispartof><rights>2001 Mosby, Inc.</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-ca1c10c811316b9d37b4932a23668dd617bc57f14cf34b61fc7da65acc79ab0c3</citedby><cites>FETCH-LOGICAL-c462t-ca1c10c811316b9d37b4932a23668dd617bc57f14cf34b61fc7da65acc79ab0c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1067/mob.2001.108333$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,4023,27922,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=861225$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11174477$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sørensen, Morten B.</creatorcontrib><creatorcontrib>Fritz-Hansen, Thomas</creatorcontrib><creatorcontrib>Jensen, Henrik H.</creatorcontrib><creatorcontrib>Pedersen, Anette T.</creatorcontrib><creatorcontrib>Højgaard, Liselotte</creatorcontrib><creatorcontrib>Ottesen, Bent</creatorcontrib><title>Temporal changes in cardiac function and cerebral blood flow during sequential postmenopausal hormone replacement</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><description>Objective: The purpose was to assess the temporal changes in cardiac function and cerebral blood flow during postmenopausal administration of estrogen with and without progestogen. Study Design: Sixteen postmenopausal volunteers were assessed during estradiol plus sequential norethindrone acetate and placebo in two 12-week periods. Temporal changes were measured by magnetic resonance flow mapping 8 times. Results: Systemic vascular resistance was reduced during estradiol (–6.9%; P &lt;.05), declined further during the addition of norethindrone acetate, and was accompanied by an increase in stroke volume (maximum increase, 5.2%; P &lt;.05) without fluid retention. Both systolic (–5 mm Hg; P =.03) and diastolic (–3 mm Hg; P =.03) blood pressure were reduced during estradiol. Cerebral blood flow was reduced after 9 weeks of hormone replacement therapy (–37 mL/min; P =.01) but increased to baseline after the addition of norethindrone acetate. Conclusions: Sequential hormone replacement therapy is associated with changes in cardiac function, which are of therapeutic potential in cardiovascular disorders. Sequential hormone replacement therapy exhibits an overall neutral effect on cerebral blood flow. (Am J Obstet Gynecol 2001;184:41-7.)</description><subject>Biological and medical sciences</subject><subject>Blood Pressure - drug effects</subject><subject>cardiac function</subject><subject>Cardiovascular Diseases - prevention &amp; control</subject><subject>cerebral blood flow</subject><subject>Cerebrovascular Circulation</subject><subject>Cross-Over Studies</subject><subject>Double-Blind Method</subject><subject>Estradiol - administration &amp; dosage</subject><subject>Estradiol - blood</subject><subject>Estrogen Replacement Therapy</subject><subject>Estrogens</subject><subject>Female</subject><subject>Genital system. Reproduction</subject><subject>Heart - physiology</subject><subject>Humans</subject><subject>Magnetic Resonance Angiography</subject><subject>Medical sciences</subject><subject>menopause</subject><subject>Middle Aged</subject><subject>norethindrone</subject><subject>Norethindrone - administration &amp; dosage</subject><subject>Norethindrone - analogs &amp; derivatives</subject><subject>Pharmacology. Drug treatments</subject><subject>Placebos</subject><subject>Postmenopause</subject><subject>Stroke Volume - drug effects</subject><subject>Vascular Resistance - drug effects</subject><issn>0002-9378</issn><issn>1097-6868</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1r3DAQhkVpaLZJz70VQaE3JxrJK9nHEtIPCPSSnIU8GicqtuRIdkv_fbTs0p56Gl7mmZfhYew9iCsQ2lzPabiSQkBNnVLqFduB6E2jO929ZjshhGx6Zbpz9raUn4coe_mGnQOAaVtjduz5nuYlZTdxfHLxkQoPkaPLPjjk4xZxDSlyFz1HyjQcwGFKyfNxSr-533KIj7zQ80ZxDXW5pLLOFNPitlLjU8pzisQzLZNDqpv1kp2Nbir07jQv2MOX2_ubb83dj6_fbz7fNdhquTboAEFgB6BAD71XZmh7JZ1UWnfeazAD7s0ILY6qHTSMaLzTe4doejcIVBfs07F3yam-V1Y7h4I0TS5S2oo1Yt8DCFnB6yOIOZWSabRLDrPLfywIe7Bsq2V7sGyPluvFh1P1Nszk__EnrRX4eAJcQTeN2UUM5S_XaZByX6n-SFHV8CtQtgUDRSQfMuFqfQr_feEFhx6agQ</recordid><startdate>200101</startdate><enddate>200101</enddate><creator>Sørensen, Morten B.</creator><creator>Fritz-Hansen, Thomas</creator><creator>Jensen, Henrik H.</creator><creator>Pedersen, Anette T.</creator><creator>Højgaard, Liselotte</creator><creator>Ottesen, Bent</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200101</creationdate><title>Temporal changes in cardiac function and cerebral blood flow during sequential postmenopausal hormone replacement</title><author>Sørensen, Morten B. ; Fritz-Hansen, Thomas ; Jensen, Henrik H. ; Pedersen, Anette T. ; Højgaard, Liselotte ; Ottesen, Bent</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-ca1c10c811316b9d37b4932a23668dd617bc57f14cf34b61fc7da65acc79ab0c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Biological and medical sciences</topic><topic>Blood Pressure - drug effects</topic><topic>cardiac function</topic><topic>Cardiovascular Diseases - prevention &amp; control</topic><topic>cerebral blood flow</topic><topic>Cerebrovascular Circulation</topic><topic>Cross-Over Studies</topic><topic>Double-Blind Method</topic><topic>Estradiol - administration &amp; dosage</topic><topic>Estradiol - blood</topic><topic>Estrogen Replacement Therapy</topic><topic>Estrogens</topic><topic>Female</topic><topic>Genital system. Reproduction</topic><topic>Heart - physiology</topic><topic>Humans</topic><topic>Magnetic Resonance Angiography</topic><topic>Medical sciences</topic><topic>menopause</topic><topic>Middle Aged</topic><topic>norethindrone</topic><topic>Norethindrone - administration &amp; dosage</topic><topic>Norethindrone - analogs &amp; derivatives</topic><topic>Pharmacology. Drug treatments</topic><topic>Placebos</topic><topic>Postmenopause</topic><topic>Stroke Volume - drug effects</topic><topic>Vascular Resistance - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sørensen, Morten B.</creatorcontrib><creatorcontrib>Fritz-Hansen, Thomas</creatorcontrib><creatorcontrib>Jensen, Henrik H.</creatorcontrib><creatorcontrib>Pedersen, Anette T.</creatorcontrib><creatorcontrib>Højgaard, Liselotte</creatorcontrib><creatorcontrib>Ottesen, Bent</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sørensen, Morten B.</au><au>Fritz-Hansen, Thomas</au><au>Jensen, Henrik H.</au><au>Pedersen, Anette T.</au><au>Højgaard, Liselotte</au><au>Ottesen, Bent</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Temporal changes in cardiac function and cerebral blood flow during sequential postmenopausal hormone replacement</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>2001-01</date><risdate>2001</risdate><volume>184</volume><issue>2</issue><spage>41</spage><epage>47</epage><pages>41-47</pages><issn>0002-9378</issn><eissn>1097-6868</eissn><coden>AJOGAH</coden><abstract>Objective: The purpose was to assess the temporal changes in cardiac function and cerebral blood flow during postmenopausal administration of estrogen with and without progestogen. Study Design: Sixteen postmenopausal volunteers were assessed during estradiol plus sequential norethindrone acetate and placebo in two 12-week periods. Temporal changes were measured by magnetic resonance flow mapping 8 times. Results: Systemic vascular resistance was reduced during estradiol (–6.9%; P &lt;.05), declined further during the addition of norethindrone acetate, and was accompanied by an increase in stroke volume (maximum increase, 5.2%; P &lt;.05) without fluid retention. Both systolic (–5 mm Hg; P =.03) and diastolic (–3 mm Hg; P =.03) blood pressure were reduced during estradiol. Cerebral blood flow was reduced after 9 weeks of hormone replacement therapy (–37 mL/min; P =.01) but increased to baseline after the addition of norethindrone acetate. Conclusions: Sequential hormone replacement therapy is associated with changes in cardiac function, which are of therapeutic potential in cardiovascular disorders. Sequential hormone replacement therapy exhibits an overall neutral effect on cerebral blood flow. (Am J Obstet Gynecol 2001;184:41-7.)</abstract><cop>Philadelphia, PA</cop><pub>Elsevier Inc</pub><pmid>11174477</pmid><doi>10.1067/mob.2001.108333</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9378
ispartof American journal of obstetrics and gynecology, 2001-01, Vol.184 (2), p.41-47
issn 0002-9378
1097-6868
language eng
recordid cdi_proquest_miscellaneous_70591102
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Biological and medical sciences
Blood Pressure - drug effects
cardiac function
Cardiovascular Diseases - prevention & control
cerebral blood flow
Cerebrovascular Circulation
Cross-Over Studies
Double-Blind Method
Estradiol - administration & dosage
Estradiol - blood
Estrogen Replacement Therapy
Estrogens
Female
Genital system. Reproduction
Heart - physiology
Humans
Magnetic Resonance Angiography
Medical sciences
menopause
Middle Aged
norethindrone
Norethindrone - administration & dosage
Norethindrone - analogs & derivatives
Pharmacology. Drug treatments
Placebos
Postmenopause
Stroke Volume - drug effects
Vascular Resistance - drug effects
title Temporal changes in cardiac function and cerebral blood flow during sequential postmenopausal hormone replacement
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T15%3A27%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Temporal%20changes%20in%20cardiac%20function%20and%20cerebral%20blood%20flow%20during%20sequential%20postmenopausal%20hormone%20replacement&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=S%C3%B8rensen,%20Morten%20B.&rft.date=2001-01&rft.volume=184&rft.issue=2&rft.spage=41&rft.epage=47&rft.pages=41-47&rft.issn=0002-9378&rft.eissn=1097-6868&rft.coden=AJOGAH&rft_id=info:doi/10.1067/mob.2001.108333&rft_dat=%3Cproquest_cross%3E70591102%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70591102&rft_id=info:pmid/11174477&rft_els_id=S0002937801891717&rfr_iscdi=true